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Abstract. Xenopus nuclear factor 7 (xnf7) is a mater- 
nally expressed protein that belongs to the B-box zinc 
finger gene family consisting of transcription factors, 
protooncogenes, and ribonucleoproteins.  Its function is 
regulated by retention in the cytoplasm from oocyte 
maturation until the mid blastula transition  (MBT) 
when it reenters the nucleus. We defined a 22-amino 
acid cytoplasmic retention domain (CRD) in xnf7 that 
functioned cooperatively with two phosphorylation 
sites within the xnf7 molecule to retain the protein in 
the cytoplasm until the MBT.  Deletion of this region 
or mutations in the phosphorylation sites resulted in 
the early entry of xnf'/into the nucleus. A  mutation 
changing one of the phosphorylation sites to a glu- 
tamic acid resulted in the prolonged retention of the 
xnf7 protein in the cytoplasm until stages 9-10, well 
past the MBT. Additionally, a mutant form of xnf7 
possessing a  second nuclear localization signal at the 
COOH terminus was retained in the cytoplasm. This 
suggests that retention of xnf7 was not due to the 
masking of its NLS as is the case with NFkB and dor- 
sal but was due to a novel anchoring mechanism in 
which the CRD interacts with an anchor protein.  The 
CRD sequence is also found in another B-box zinc 
finger protein that is also retained in the cytoplasm 
until the MBT in the newt.  Therefore, we believe that 
this may be an important mechanism whereby the 
function of a number of nuclear proteins is regulated 
during development, 
important problem in development concerns the strat- 
egy used by the embryo to regulate  nuclear  pro- 
cesses during embryogenesis.  One mechanism used 
in a variety of systems is selective transport of proteins into 
the nuclei at specific times or in specific regions of the em- 
bryo during  development  or cellular differentiation  (Hunt, 
1989; Nigg et al.,  1991; Schmitz et al., 1991; Silver,  1991; 
Forbes,  1992;  Whiteside and  Goodbourn,  1993).  Several 
notable  examples  include  the  transcription  factor NF-kB 
which functions  in the activation of the x chain gene during 
B lymphocyte differentiation (Lenardo and Baltimore,  1989; 
Ghosh and Baltimore,  1990; Kerr et al.,  1991) and the nu- 
clear/cytoplasmic distribution  of the dorsal  gene product 
during  development  in  Drosophila which  controls  dor- 
sal-ventral axis formation  (Hunt,  1989; Roth et al.,  1989; 
Rushlow et al., 1989; Schmitz et al., 1991; Steward,  1989; 
Govind and Steward,  1992). 
Another example of selective nuclear transport of proteins 
during  development  is  in  the  vertebrate  Xenopus laevis 
(Dreyer  et  al.,  1983;  Dreyer,  1987).  Using  immuno- 
histochemistry with antibodies against GV proteins,  Dreyer 
(1987)  described the  developmental  fate  of a  number  of 
maternal  nuclear proteins which were first detected in the 
oocyte nucleus (GV). After oocyte maturation these proteins 
were released into the cytoplasm after which some immedi- 
ately reentered the nuclei (early shifting)  while others re- 
mained in the cytoplasm until specific stages during develop- 
ment (late shifting). 
Several of the late shifting proteins reenter the nucleus at 
the mid blastula transition  (MBT)) This is a crucial time 
during Xenopus  development when the zygotic genome is ac- 
tivated and there is a dramatic change in the cell cycle (New- 
port and Kirschner,  1982; Etldn,  1988). Thus, it is likely that 
some of these proteins play important  roles in regulating 
these processes. 
We have analyzed  one of the late shifting proteins,  xnf'/ 
(Xenopus nuclear factor 7), a maternally  expressed putative 
transcription  factor whose protein product is retained in the 
cytoplasm until it reenters the embryonic nuclei at the MBT 
(Dreyer et al., 1983; Miller et al., 1989, 1991; Reddy et al., 
1991). Xnf7 is a member of a novel family of zinc finger pro- 
teins,  the B-box family, consisting  mainly of transcription 
Address all  correspondence to  L.  D.  Etldn,  Department of Molecular 
Genetics, University of Texas M.D. Anderson Cancer Center,  1515 Hol- 
combe Blvd., Houston, TX 77030. 
1. Abbreviations  used in this paper:  CRD, cytoplasmic retention domain; 
MBT, mid blastula transition; NLS, nuclear localization signal; xnf7, Xeno- 
pus nuclear factor 7. 
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tion  mutants  of xnf7  in  nuclei 
during  development.  (A)  Dia- 
gram of deletion constructs used 
in  these  experiments.  (B)  In 
vitro-transcribed  mRNA  made 
from the above constructs was in- 
jected  into  fertilized  eggs.  In- 
jected embryos at stage 7 and 9 
were fixed, sectioned and treated 
with the T7 polyclonal antibody 
followed  by  immunoperoxidase 
staining.  The  panels  represent, 
xnf'/A145-273 injected embryos 
analyzed  at  stage  7  and  9; 
xnf'/A280-548  injected embryos 
at stage 7 and 9; and xnfT-NLS 
injected  embryos  analyzed  at 
stage 7 and 9. Arrows are point- 
ing to nuclei. P, phosphorylation 
sites. 
factors and protooncogenes (Reddy and Etkin,  1991; Reddy 
et al.,  1992; Freemont,  1993).  When xnf7 is released into 
the cytoplasm during oocyte maturation it is hyperphosphor- 
ylated, however, it is dephosphorylated coincident with nu- 
clear reentry at the MBT.  Previously, we have mapped one 
of the phosphorylation sites to threonine 103 which is adja- 
cent to the NLS (Reddy et al.,  1991;  Li and Etldn,  1993). 
Additionally, there are several other putative phosphoryla- 
tion sites located at threonines 209,  212,  and 218  between 
the two zinc finger domains. It is likely that these sites are 
phosphorylated at maturation (Li, X., and L. D. Etkin, un- 
published  observations).  Therefore,  the  potential  nuclear 
function of xnf7 is suppressed by its retention in the cyto- 
plasm before the MBT and its nuclear/cytoplasmic distribu- 
tion may be regulated by its state of phosphorylation. 
The xnf7  nuclear localization signal (NLS) is found be- 
tween amino acids  106  and  120 and is very similar to the 
bipartite basic NLS of nucleoplasmin (Reddy et al.,  1991). 
However,  nucleoplasmin, unlike xnf7  reenters the nucleus 
immediately following fertilization (Dreyer  et  al.,  1983). 
Recently, we analyzed the function of the xnf7 NLS in oo- 
cytes and developing embryos and showed that the bipartite 
basic NLS functions efficiently in nuclear transport suggest- 
ing that the retention of xnf7 in the cytoplasm is due to a pro- 
cess that either interferes with the function of the NLS or an- 
chors it to a subcellular structure or complex (Li and Etldn, 
1993). 
In the present study we have identified a cis-acting cyto- 
plasmic retention domain (CRD) in xnf7 and have shown that 
phosphorylation is intimately involved in its function. Also, 
we found that xnf7 was retained in the cytoplasm even when 
a  second NLS was added at the COOH terminus suggesting 
that its retention is due to intermolecular interactions with 
a cytoplasmic anchor involving the CRD. NFkB, on the other 
hand, entered the nucleus upon the addition of a second NLS 
at the COOH-terminal end of the protein indicating that it 
was retained through a mechanism that masked the normal 
NLS. Therefore, the cytoplasmic retention of xnf7 may in- 
volve a  novel  mechanism  different from  that  of NFkB or 
dorsal. 
Materials and Methods 
Expression  Vectors 
A vector was constructed for synthesis  of  xnf7 mRNA. The vector consisted 
ofpBS, into which a synthetic  oligonucleotide  containin~  the 5' untranslated 
sequences of  the Xenopus  B-globin  gene and a 12-amino acid-long T7 viral 
coat protein tag was inserted at the XbaI and KpnI sites. The T7 viral coat 
peptide was used to distinguish the exogenous xnf7 from the endogenous 
protein with polyclonai antibodies. The xnf7-8 eDNA (this cDNA lacks 30 
NH2-terminal amino acids of the full length eDNA to ensure use of the 
globin translational start site (Reddy et al., 1991) was cloned into the EcoRI 
site of the vector, fusing it in frame with the upstream T7 sequence. The 
xnf7-1 construct was made by deleting the NH2-terminsl 128 amino acids, 
including  the NLS. Xnf'/A145-273 and xnfTA280-548 were constructed by 
interuai deletions of the xnfT-8 cDNA using convenient restriction sites. 
Xnf7NLS was constructed by inserting the NLS oligonucleotide (5' AA- 
CTCCCCAGAAGAGAAAGATTGAGGAACCTGAGCCTGAACCGA- 
AGAAAGCAAAG  3' coding for Lys Thr Pro Gin Lys Arg Lys Ile Gin Glu 
Pro Glu Pro Ghi Pro Lys Lys Ala Lys) upstream of  the NH2-terminal  trun- 
cated xnf7-1 cDNA. XnfT-1-CRD was made by cloning an oligonucleo- 
tide containing the CRD  sequence downstream (31 of the NLS in the 
xnfTNLS construct.  This oligenuclcotide consisted of 5'GAAGAGTAT- 
TACGCGCATTACGT~TTGAACCGCCGCCAAAACGAATGG- 
GTGGACAAATCTCGT3'  coding for Glu Glu Tyr Ala His Tyr Val Gly Leu 
Ash Arg Arg Gin ASh Glu ~  Vai Asp Lys Ser Arg. Xnf7-SC-NLS  and 
xnf7-1C-NLS were generated by inserting an NLS oligonucleotide at the 
C-terminus of the xnf'/-8 and xnf7-1, respectively.  For xnf7ACRD (452 to 
73), fragments upstream and downstream of the CRD were amplified by 
PCR, ligated, and cloned into the same expression vector as above. All the 
phosphorylation mutants were generated by the PCR  soeing technique 
(Horton et al., 1990). The PCR soeing is performed as follows: four oligo- 
nucleotides are required for making each mutation, including the 5' and 3' 
end oligonucleotides  from the expression vector flanking  the insert and two 
complementary oligonucleotides containing the mutation (listed below). 
Three PCR reactions are performed for each mutation. The first PCR am- 
plifies the upstream fragment  using the 5' oligonuclcotide  and one of  the mu- 
tant oligonucleotides as the primers. The second PCR is to amplify the 
downstream fragment using the 3' oligonucleotide  and the complementary 
mutant oligonucleot/de as primers. The last PCR reaction is to lignte the 
upstream and downstream  fragments  by using 5' and 3' end oligonucleotides 
as primers and the PCR products from reaction 1 and 2 as templates. Oligo- 
nucleotides containing the mutations for different  mutants are listed as fol- 
lows: oligonucleotides for making XnfTPl are 5' ~_AAAGGCGCCCCA- 
GAAGAGAAAG  3' (nt 336 to 360) and its complement 5' CTGOGGCGC- 
CTTTGAGTCTGC~TG 3'  Oligonucleotides for mai~g Xnf7P2 are 5' 
GCCTGTGCGCCGGTC~C'rGTAGAGAAAA~?~.ACGG  3'  (nt 
654 to 693) and its complement 5~CGTGCCTTTTICTCTACAGGTG- 
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5' GGCCAAGAAAGCCGCCTGTGAGCCGGTCGAACCTGTAGAG- 
AAAAAGGCACGC~CC 3' (nt 644 to 696) and its complementary 5' CCA- 
GGGC~CGTTCCTTTTTCTCTACAGGTTCGACCGGCTCACAGCK2- 
GGC 3'. All constructs were sequenced and several independent clones were 
analyzed for each mutant to ensure against potential mutations generated 
during PCR. 
Microinjection of  Embryos and Oocytes 
Eggs were fertilized in vitro. Eggs were transferred into lx modified Barth 
saline (MBS) and microinjected as previously described (Etkin et al., 1984; 
Etkin and Pearman, 1987).  I0 ng of RNA was injected into the equatorial 
region of the one-cell embryos.  One hour after microinjection, embryos 
were transferred into 0.1x MBS and allowed to develop. Oocytes were in- 
jected in the equatorial region with 10 ng of RNA. 
Immunoperoxidase Staining of  Sections 
Embryos were  fixed in 100%  methanol at 4°C  overnight,  embedded in 
Paraplast Plus (Oxford  Labware,  St.  Louis, MO), and serially sectioned 
into 10-#m sections. Immunoperoxidase staining was carried out according 
to  Cornish  et  al.  (1992).  Deparattinized  and  hydrated  sections  were 
bleached in 6% hydrogen peroxide in methanol for 20-30 rain. After two 
10-rain PBS washes, nonspecific staining was blocked with a 1-h incubation 
in a blocking buffer consisting of 10% goat serum and 3 % BSA in TBS with 
0.5% Tween 20 (TBST).  Sections were incubated 1 h in a 1:50-1:200 dilu- 
tion of the L24 polyclonal antibody (Reddy et al., 1992) in blocking buffer 
then washed two times for 10 rain each in PBS. For control sections no pri- 
mary antibody was used. The sections were treated with the secondary anti- 
body (1:50 dilution of goat anti-rabbit conjugated with pcroxidase)  for 1 h 
and washed 2  x  10 min in PBS. The color reaction was initiated with 1 
mg/ml DAB  +  0.03 % H202 in PBS for 5 rain and was stopped by two 
5-rain washes  with water.  The sections were  counterstalned with either 
hematoxylin or Azur B  and mounted with Permount (Fisher Scientific, 
Pittsburgh, PA) or a  1:1 dilution of PBS with glycerol. 
Labeling of  Exogenous xnf7 Mutant Phosphoproteins 
during Oocyte  Maturation 
Maturation of defolliculated  injected oocytes was induced by culturing in 
1× MBS with 10 #g m1-1 progesterone (Sigma Chemical Co., St.  Louis, 
MO). Maturation (GVBD) was determined by the presence of a white spot 
in the animal pole or by dissection of oocytes.  To study phosphorylation, 
oocytes were incubated in 0.5 mCi m1-1 inorganic 32p-phosphate (carrier- 
free; Amersham Corp., Arlington Heights, IL) for4 h in lxMBS. The free 
label was removed by extensive washing with lxMBS and oocytes were ma- 
tured with progesterone.  Protein extracts were prepared by homogenization 
of oocytes in a buffer consisting of 10 mM Tris-HCi,  pH 8.0, 10 mM DDT, 
0.1% Triton X-100, and 5 mM EDTA.  Protease inhibitors included 0.1-1 
mM PMSF, 0.5 #g m1-1 leupopfin and 0.7 t~g m  1-1 pepstatin. Phosphatase 
activity was inhibited  by the addition of 50 mM fl-glyceropbosphate  (Sigma 
Chemical Co.). Protein concentrations of extracts were determined using 
the Bio Rad Protein kit (Bio Rad Laboratories, Richmond, CA) with BSA 
as a standard. Exogenous and endogenous xnf'/was immunopreeipitated ac- 
cording to Li and Etkin (1993) and analyzed by SDS-PAGE and autoradiog- 
raphy. 
Results 
Retention of  xnfl in the Cytoplasm Is Dependent 
on the Presence of  a 22-residue CRD Located between 
Amino Acids 52 and 73 
Previous studies (Li and Etkin, 1993) suggested that reten- 
tion of xnf7 in the cytoplasm was due to either a mechanism 
that interfered with the function of its NLS or an anchor 
mechanism tethering the protein to a cytoplasmic complex 
or structure. 
To map putative retention domains in xnf7 we created a 
series of  deletion mutants and determined whether they were 
retained in the cytoplasm by injecting synthetic mRNA into 
Table L Comparison of CRD Sequences between xnJ7 
and PwA33 
Gene  Amino acids  Sequence 
xnf7  52-73  EEYYAHYVGLNRRQNEWVDKSR 
PwA33  79-100  EEFYVHYVGLNRRQNEWVDKSR 
fertilized eggs. Injected embryos were analyzed at different 
stages during development using immunostaining with the 
T7  antibody to detect the epitope tagged protein.  Dele- 
tion mutants included xnf'/A145-273,  xnfTA280-548,  and 
xnfT-NLS,  which lacks amino acids 1-128 but contains an 
oligonucleotide with the NLS at the NH2  terminus  (Fig. 
1 A).  Fig.  1 B  shows that at stage 7  xnfTA145-273  and 
xnf7A280-548 appeared in the cytoplasm, while at stage 9 
all were nuclear. This was identical to the time of nuclear en- 
try of the xnfT-8 construct and endogenous xnf7 (Reddy et 
al., 1991; Li and Etkin, 1993). The xnf7NLS protein, on the 
other hand, was detected within the nucleus by stages 6-7, 
well before the MBT and the nuclear accumulation of the 
xnf'/-8 and other mutant proteins. These data show that a 
signal located within the domain from amino acids 1-128 was 
necessary for the retention of xnf7 in the cytoplasm during 
early development. 
Recently, the protein product of another B box zinc finger 
gene (PwA33),  cloned from the newt Pleurodeles waltli was 
also shown to be retained in the cytoplasm until MBT (Bel- 
lini et al,, 1993).  The NH2 terminus of the gene was differ- 
ent from that of xnf7 except for a 22-amino acid domain, 
which was 97% identical (Table  I).  Therefore, we tested 
the  function of this domain in the cytoplasmic retention 
of xnf7 by creating a  mutant gene lacking this sequence 
(xnf7ACRD). 
Synthetic mRNA from deletion mutant xnfTACRD was in- 
jected into fertilized eggs and the fate of the protein followed 
by immunostaining. Fig.  2  A  shows that while wild-type 
xnf7-8 was not detected at stage 7 the mutant was detected 
in the nucleus by stage 6-7 (Fig. 2 B). These data suggest 
that retention of xnf7 in the cytoplasm before MBT was de- 
pendent on the presence of the 22-amino acid cis-acting 
CRD within the NI-I2 terminus. 
The translational efficiency and the stability of the protein 
from each of  the deletion mutants was analyzed by extraction 
of protein from injected oocytes and embryos and analysis 
by Western blotting. We also analyzed the newly synthesized 
exogenous xnf'/protein by labeling with [3sS]methionine, 
immunoprecipitation,  and  analysis  by  SDS-PAGE  and 
fluorography. We found no differences between the amount 
of synthesis or the stability of the protein produced by the 
various constructs (data not shown).  The apparent differ- 
ences in intensity of staining in the cytoplasm surrounding 
the nucleus with some of the constructs were due to the as- 
sociation of the wild-type protein with structures located at 
the poles that may be centrosomes, while some of the dele- 
tion  mutants  were  distributed  evenly  throughout  the 
cytoplasm. In all of these cases the nucleus/cytoplasm ratio 
of the exogenous protein at stage 7 was similar. Also, when 
first detected in the nucleus the protein is localized in an 
asymmetric pattern (see Fig. 2 B) due to its association with 
the chromosomes which are located to one side of the nu- 
The Journal of Cell Biology, Volume 124, 1994  10 Figure 2.  Role of the CRD in cytoplasmic  retention. In vitro transcribed RNAs from the xnfT-8 and xnfTACRD constructs were injected 
into fertilized eggs. A shows the cytoplasmic localization  of the xnfT-8 protein at stage 8; B shows the nuclear localization  of the xnfTACRD 
protein by stage 7. Arrows point to nuclei. Diagram of constructs is shown below. 
Figure 3.  The CRD sequence functions at a different position in xnfT. In vitro-transcribed mRNA from the xnf7-1 CRD construct was 
injected into the cytoplasm of fertilized eggs. Analysis for nuclear localization was performed  at stage 7 and 9. The arrows point to the 
nuclei and the diagram of the constructs is shown below. 
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phorylation sites effects the nu- 
clear retention of xnfT. (,4) Dia- 
gram of the constructs used to 
make  the  in  vitro  transcribed 
RNA; (B) examples of embryos 
at stage 7  and stage 9  injected 
with: the xnf'/P1 mutant in which 
the thr of the first phosphoryla- 
tion site was mutated to ala, the 
xnffP2 mutant in which the three 
thr at positions 209, 212, and 218 
were  mutated  to  ala,  and 
xnf'/PIP2  in  which both  phos- 
phorylation sites were mutated. 
cleus as determined by DAPI staining. Xnf'/later acquires 
a more uniform staining pattern throughout the nucleus. 
CRD Function Is Not Dependent upon Surrounding 
NHrterminal Sequences 
We tested the ability of the 22-amino acid CRD to function 
autonomously by placing the CRD between the NLS and the 
first zinc finger domain in the xnf7-1NLS construct (xnf7- 
1CRD). This eliminated the possibility that sequences adja- 
cent to the 22-amino acid CRD at the NH2 terminus were 
involved in its function. Fig.  3 shows that the xnf7-1NLS- 
CRD protein was retained in the cytoplasm until the MBT. 
Thus, deleting other NH2-terminal sequences surrounding 
the CRD did not effect its ability to function. 
We also tested the ability of the CRD to function autono- 
mously in a beterologous protein, pyruvate kinase (pk), by 
making a construct containing the pk xnf7 NLS and CRD 
with the pk eDNA. The protein from this construct was de- 
tected in nuclei prior to the MBT and was not retained in the 
cytoplasm (data not shown). This suggests that the CRD se- 
quence may require the proper context within the xnf7 pro- 
tein for proper functioning. Alternatively, it is possible that 
the positioning of the CRD in the pk protein may have inter- 
fered with its function. Further analysis will be required to 
fully explain this result. 
CRD Function Is Dependent 
upon the Phosphorylation  of One of Two Sites 
within xnf7 
Previous studies showed a tight correspondence between the 
hyperphosphorylation of xnf7 which occurs at maturation 
and its retention in the cytoplasm (Miller et al.,  1991). We 
identified a phosphorylation site at threonine 103 (referred 
to as site 1) and potential sites at threonines 209, 212, and 
218 (referred to as site 2), based on homologies to consensus 
phosphorylation sequences and phosphoamino acid mapping 
analysis (Reddy et al.,  1991). In the following experiments 
we use a functional assay to determine the role of  phosphory- 
lation in the cytoplasmic retention of xnf7 by creating a se- 
ries of  point mutations changing these threonines to alanines 
to inhibit phosphorylation of these sites (Fig. 4 A). 
After injection of RNA from site 1 mutants (xnf7P1) or site 
2 mutants (xnf7P2), mutant protein behaved like the wild- 
type xnf7 protein, entering the nucleus at MBT (Fig. 4 B). 
However, when both sites 1 and sites 2 were mutated in the 
same molecule (xnfTPIP2) the protein entered the nucleus by 
stage 6-7 (Fig. 4 B).  These data strongly suggest that the 
phosphorylation of either site 1 or site 2 was required for the 
proper function of the CRD and that mutation of both phos- 
phorylation sites resulted in the loss of function of the CRD. 
They also indicate that the function of phosphorylation sites 
1 and 2 is redundant in the function of the CRD. In addition, 
this experiment indicates that xnf'/, which is normally phos- 
phorylated during oocyte maturation, can be phosphorylated 
during early cleavage stages. 
To further verify the importance of phosphorylation of 
sites 1 and 2 we created a mutant xnf'/protein by replacing 
the threonines at site 2 with glutamic acid residues (xnfTThr- 
Glu). The rationale for this experiment was that the nega- 
tively charged glutamic acids would mimic the phosphoryla- 
tion of site 2  and xnf7 would remain cytoplasmic. Fig.  5 
shows that the protein produced by xnf7Thr-Glu mutant was 
indeed retained in the cytoplasm at stage 10, well past the 
MBT, demonstrating the importance of the phosphorylation 
of this site in the functioning of the CRD. 
It is possible that removal of the CRD sequence effects the 
phosphorylation of xnf7 resulting in early entry of the pro- 
tein into the nucleus. To determine this we tested the ability 
of mutant xnf'/lacking the CRD sequence (xnf/ACRD) to 
be hyperphosphorylated during oocyte maturation by inject- 
ing synthetic mRNA from this mutant into oocytes. Oocytes 
were incubated in 32p and matured by adding progesterone. 
Phosphorylated  xnf7  was  analyzed by  immunoprecipita- 
tion with the L24 polyclonal antibody against xnf7 and auto- 
radiography according to Reddy et al. (1991). Fig. 6 shows 
that  the  endogenous  wild-type  xnf7  and  the  exogenous 
xnf'/ACRD mutant were hyperphosphorylated  during oocyte 
maturation. Although we did not analyze the precise sites 
phosphorylated during maturation these results demonstrate 
that the removal of the CRD sequence does not effect hyper- 
phosphorylation of xnf7 which most likely includes sites 1 
and 2. 
Retention in the Cytoplasm  Involves an 
Anchoring Mechanism 
There are several possibilities regarding the mechanism in- 
volved in the cytoplasmic retention of xnf7.  These include 
an intramolecular mechanism in which the protein structure 
changes upon phosphorylation, placing the CRD over the 
NLS to mask its function, or a mechanism in which hyper- 
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phosphorylated during oocyte matu- 
ration.  Oocytes were injected with 
xnfTACRD mutant  mRNA and in- 
cubated with 0.5 mCi/ml 32P-carder 
free inorganic phosphate for 4 h. Oo- 
cytes  were  matured  in  vitro  with 
progesterone.  After  maturation  10 
oocytes  from  each  group  were 
homogenized  and  endogenous  and 
exogenous xnf7 was immunoprecipi- 
tated using the L24 polyclonal anti- 
body  that  recognizes  both  forms 
(Reddy et al., 1991). The endogenous and exogenous forms can be 
distinguished from one another on the basis of mobility on SDS- 
PAGE gels. The radioactive immunoprecipitates were visualized by 
autoradiography. (Lane 1) endogenous (en)  xnf7 and exogenous 
mutant xnf7ACRD (ex)  protein from oocytes prior to maturation; 
(lane 2) protein from the same group of oocytes as in lane 1 after 
oocyte maturation; (lane 3) endogenous xnf'/protein from nonin- 
jected oocytes before maturation: (lane 4) protein from the same 
group of oocytes as in lane 3 after oocyte maturation. 
phosphorylation anchors xnf'/to a cytoplasmic anchor pro- 
tein through interaction with the CRD. 
To distinguish between these two alternatives we created 
a construct in which an extra NLS was placed at the carboxy- 
terminus of the xnf7-8 protein (xnf'/-8C-NLS). The expecta- 
tion  was  that  if cytoplasmic retention was  due  to  an  in- 
tramolecular mechanism the extra NLS would result in early 
entry into the nucleus;  if on the other hand an anchoring 
mechanism was involved, the extra NLS would have no effect 
and the protein would enter the nucleus at the MBT. As a 
control for the proper function of the NLS at the COOH ter- 
minus  we placed the NLS on the xnf'/-1  construct, which 
lacked the CRD  and NLS at the NH2 terminus  (xnf7-1C- 
NLS). 
Fig. 7 A shows that the xnf7-1C-NLS protein lacking the 
CRD entered the nucleus by stage 6-7,  indicating that the 
NLS placed at the COOH terminus functioned efficiently. 
However, the xnf'/-8C-NLS protein product which possessed 
the CRD and the COOH-terminal NLS was retained in the 
cytoplasm until MBT, suggesting that an anchoring mecha- 
nism was responsible for cytoplasmic retention (Fig.  7,  B 
and C). 
Discussion 
The retention of xnf7 in the cytoplasm before the MBT illus- 
trates an important level of regulation of nuclear proteins and 
is  one of the  few  reported examples  of selective nuclear 
transport used in a developing system. We have identified a 
cis-acting domain, the CRD, located between amino acids 52 
and  73  that  is  required  for the  retention of xnf7  in  the 
cytoplasm. The CRD likely functions by interacting with an 
anchor protein in the cytoplasm, and its function is depen- 
dent upon the phosphorylation of one of  two phosphorylation 
sites on the xnf'/protein. 
Selective nuclear transport has been demonstrated in  a 
number of instances of proteins involved in cell regulatory 
processes including the SW15 gene product whose nuclear 
or cytoplasmic localization is regulated during the cell cycle 
by the phosphorylation state  of the protein  (Moll  et al., 
1991); lamin B2 in which the phosphorylation of protein ki- 
nase C  sites  inhibits  its nuclear import (Hermekes et al., 
1993); Simian Virus 40 T antigen in which phosphorylation 
effects its entry into nuclei (Jarls et al., 1991); and p53, a tu- 
mor suppressor gene, whose function may be regulated by 
retention in the cytoplasm (Moll et al.,  1992; Gannon and 
Lane,  1991). In the case of the glucocorticoid receptor it is 
known that binding to the hsp 90 protein in the cytoplasm 
interferes with the function of the NLS and that nuclear lo- 
calization is dependent upon the presence of the hormone 
which causes dissociation of the hsp 90 from the receptor 
(Picard and Yamamoto,  1987;  for review see Pratt,  1992). 
During development the dorsal gene product in Drosoph- 
i/a is present in all regions of the embryo, but in the ventral 
region it is localized in the nucleus, while in the dorsal region 
it is in the cytoplasm. The variation in nucleocytoplasmic 
compartmentalization of the dorsal gene product in different 
regions of the embryo may be due to its interaction with the 
cactus gene product resulting in anchoring of the dorsal pro- 
tein in the cytoplasm or the masking of the NLS. This inter- 
action may be augmented by differential phosphorylation of 
the dorsal protein in different regions of the embryo, which 
may affect its binding to the cactus protein (Roth et al., 1989; 
Rushlow et al.,  1989;  Steward,  1989). 
Interestingly, both NFk B and dorsal are related in that 
they share homology with the c-rel protooncogene (Kieran 
et al.,  1990; Ghosh et al.,  1990). It is known that the IkB 
partner of NFkB contains a number of ankyrin repeats that 
are associated with proteins that interact with the cytoskele- 
ton. Thus, one possible mechanism for cytoplasmic reten- 
tion of NFkB, and perhaps, dorsal is that their partners inter- 
act with the cytoskeleton to retain them in the cytoplasm. 
Release is triggered by changes in phosphorylation of either 
the  anchor or  nuclear protein.  However, recent evidence 
shows that the cytoplasmic retention of NFkB may be due 
to a mechanism in which binding to IkB masks the function 
of the NLS. Therefore, cytoplasmic retention of NFkB may 
not  involve  anchoring  to  a  subcellular  structure  or  the 
cytoskeleton (Blank et al.,  1991; Begg et al.,  1992; Henkel 
et al.,  1992). 
Xnf7 is phosphorylated at oocyte maturation and remains 
predominately in  the  hyperphosphorylated state  until  the 
Figure 5.  The mutation of phosphorylation site 2 to glutamic acid results in retention of xnf7 in the cytoplasm. Synthetic mRNA from 
the xnf7thr-glu mutant was injected into fertilized eggs. The developing embryos were analyzed at stage 7, 8, and 9. The arrows are pointing 
to the nuclei and the construct is diagrammed below. 
Figure 7. The xnf7 protein is retained in the cytoplasm through an anchoring mechanism. Synthetic mRNAs produced from the xnf7-1C-NLS 
and the xnf7-SC-NLS  construct were injected into the cytoplasm of fertilized eggs. (A) The accumulation of  the mutant xnf7-1C-NLS  protein 
in nuclei at stage 7; (B) the mutant xnf7-8C-NLS was not detected in nuclei at stage 7; however, (C) the protein is detected in the nuclei 
at stage 9. Arrows point to nuclei and the constructs are diagrammed below. 
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entry (Miller et al.,  1991). This tight correlation between 
hyperphosphorylation and retention in the cytoplasm sug- 
gested that phosphorylation is involved in its localization. In- 
deed,  xnf7  is  phosphorylated  in  vivo  at  numerous  sites 
throughout the molecule. It acquires a basal level of phos- 
phorylation when it enters the GV during oogenesis and a 
second level of hyperphosphorylation  during oocyte matura- 
tion (Li et al.,  1993; Li, X., and L. D. Etldn, unpublished 
observations).  Sites  throughout the entire  molecule most 
likely including threonines at both site I (threonine 103) and 
site 2 (threonines 209, 212, and 218) are phosphorylated in 
vivo during oocyte maturation (Reddy et al.,  1991; Li, X., 
and L. D. Etkin, unpublished observations). 
We have two lines of  evidence indicating that phosphoryla- 
tion of these two sites within the xnf7 protein is important 
in the function of the CRD sequence. The first is that muta- 
tions (thr to ala) of both sites results in early entry into the 
nucleus. The second is that changing the threonines of the 
second site to glutamic acids results in the retention of xnf7 
in the cytoplasm. The fact that the two phosphorylation sites 
can substitute for one another in the functioning of the CRD 
suggests a redundancy of function. This also implies a mech- 
anism involving cross-talk between the phosphorylation sites 
and the CRD sequence.  The xnf7ACRD protein is phos- 
phorylated during oocyte maturation suggesting that deletion 
of the  CRD  does  not  affect the  phosphorylation of the 
protein. 
When a second NLS is added to the COOH-terminal end 
of NFkB it enters the nucleus suggesting that cytoplasmic 
retention may be due to a mechanism in which IkB binds to 
the NFkB molecule and masks the NLS (Begg et al., 1992). 
Therefore, the cytoplasmic retention of NFkB may not in- 
volve anchoring to a subcellular structure or the cytoskele- 
ton.  Our data showing that the protein produced from the 
xnf7-1C-NLS construct in which a second NLS is added to 
the COOH-terminal end of the molecule is retained in the 
cytoplasm before the MBT strongly suggests that xnf7 reten- 
tion is due to the physical interaction of the CRD with a fixed 
anchor protein or subcellular structure. Our model (Fig. 8) 
is that the phosphorylation of  one of the two domains (at site 
1 or site 2) results in a structural change in the molecule that 
exposes the CRD. This altered structure permits interaction 
of the CRD with the cytoplasmic anchor. When the embryo 
reaches the blastula stage, xnf7 is dephosphorylated and the 
protein is released from the anchor and is free to enter the 
nucleus. The changes in phosphorylation of xnf'/indicates 
that a signal transduction pathway involving both kinase and 
phosphatase activities regulates the localization of proteins 
such as xnf7. The elucidation of this pathway will be impor- 
tant in furthering our understanding of early developmental 
events. 
There  are  several  other  late  shifting proteins  such  as 
nucleolin,  a  component  of the  nucleolus  (Messmer  and 
Dreyer, 1993),  and PwA33, a potential RNP protein that is 
a  member of the B-box zinc finger family (Bellini et al., 
1993), that have been cloned and characterized. PwA33 pos- 
sesses CRD sequence that is 97 % identical to xnfT, however, 
it is not known whether PwA33 is a phosphoprotein. Nucleo- 
lin does not possess a domain that has sequence homology 
to  the  xnf7  and  PwA33  CRD  sequence  but  is  hyper- 
phosphorylated when located in the cytoplasm and dephos- 
Figure 8. Xnf7 is retained in the cytoplasm during early cleavage 
stages. During this time it is phosphorylated at sites 1 and 2 and 
bound to an anchor protein through the CRD. Near the time of the 
MBT xnf7 is dephosphorylated  resulting in its release from the an- 
chor protein and the utilization of the NLS. It accumulates in the 
nuclei at a rapid rate. 
phorylated when it enters the nucleus at the MBT (Messmer 
and Dreyer,  1993).  In nucleolin there may be a structural 
motif similar to the xnf7 CRD that functions in cytoplasmic 
retention or alternatively there may be several independent 
mechanisms involved in  the  late  shifting proteins  which 
results in their retention properties. The answer to this ques- 
tion will have to await the cloning of the genes for other late 
shifting proteins in amphibians. However,  it is evident that 
cytoplasmic retention is an important strategy used to regu- 
late the function of  many transcription factors, oncoproteins, 
and other nuclear proteins during development and cellular 
differentiation. 
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